Keyword Analysis & Research: bivacor

Keyword Analysis


Keyword CPC PCC Volume Score Length of keyword
bivacor0.790.66453287

Keyword Research: People who searched bivacor also searched

Keyword CPC PCC Volume Score
bivacor0.240.5302550
bivacor heart1.160.6928082
bivacor tah0.040.9545114
bivacor stock0.70.5414011
bivacor logo0.010.794190
bivacor huntington beach1.560.8111775
bivacor human trials0.780.8951472
bivacor artificial heart1.091322032
bivacor oneventures0.191615488
bivacor 20241.120.1236434
bivacor jobs1.120.4782199
bivacor ceo1.20.7289945
bivacor 20230.640.3114770
bivacor total artificial heart0.440.488119

Search Results related to bivacor on Search Engine

  • BiVACOR, Inc. – Replacing Hearts. Restoring Lives.

    bivacor.com

    https://bivacor.com/

    WebBiVACOR® Receives $13 Million to Support Clinical Trials for the Company’s Total Artificial Heart. Replacing Hearts. Restoring Lives. HEART FAILURE Heart Failure (HF) is a devastating disease

    DA: 35 PA: 30 MOZ Rank: 2

  • News – BiVACOR, Inc.

    bivacor.com

    https://bivacor.com/news/

    WebDownload Article. Mar 29th, 2023. BiVACOR ® Receives $18 Million in Funding to Move the Total Artificial Heart Through First in Human Studies. Funds will support studies of its Total Artificial Heart for the first in human early feasibility studies. Download Article. Sep 14th, 2021. BiVACOR at Gold Coast, Queensland, Australia.

    DA: 96 PA: 48 MOZ Rank: 53

  • US FDA Grants the BiVACOR Total Artificial Heart IDE …

    bivacor.com

    https://bivacor.com/wp-content/uploads/2024/02/US-FDA-Grants-the-BiVACOR-Total-Artificial-Heart-IDE-Approval-for-First-in-Human-Early-Feasibility-Study.pdf

    WebUS FDA Grants the BiVACOR Total Artificial Heart IDE Approval for First-in-Human Early Feasibility Study. Huntington Beach, CA/Gold Coast, Australia/Houston, TX [November 29, 2023] – BiVACOR, Inc., a clinical-stage medical device company developing a total artificial heart, today announced the United States Food and Drug Administration (FDA ...

    DA: 86 PA: 69 MOZ Rank: 9

  • US FDA Grants the BiVACOR Total Artificial Heart IDE Approval …

    businesswire.com

    https://www.businesswire.com/news/home/20231129194008/en/US-FDA-Grants-the-BiVACOR-Total-Artificial-Heart-IDE-Approval-for-First-in-Human-Early-Feasibility-Study

    WebNov 29, 2023 · HUNTINGTON BEACH, Calif. & GOLD COAST, Australia & HOUSTON-- ( BUSINESS WIRE )--BiVACOR, Inc., a clinical-stage medical device company developing a total artificial heart (TAH), today announced...

    DA: 98 PA: 19 MOZ Rank: 29

  • This Maglev Heart Could Keep Cardiac Patients Alive

    ieee.org

    https://spectrum.ieee.org/this-maglev-heart-could-keep-cardiac-patients-alive

    WebAug 22, 2019 · With just one moving part, the Bivacor heart is able to send oxygen-rich blood out to the body and return oxygen-depleted blood to the lungs. We had to overcome many technical challenges to make an artificial heart that’s small, biocompatible, energy efficient, and durable.

    DA: 68 PA: 32 MOZ Rank: 54

  • FDA approves early feasibility study for total artificial heart …

    cardiovascularbusiness.com

    https://cardiovascularbusiness.com/topics/clinical/heart-failure/fda-early-feasibility-study-total-artificial-heart

    WebDec 1, 2023 · BiVACOR, an international medical device company with headquarters in the United States and Australia, has received approval from the U.S. Food and Drug Administration (FDA) to kick off an early feasibility study (EFS) for its total artificial heart (TAH) technology.

    DA: 2 PA: 27 MOZ Rank: 19

  • BiVacor wins FDA IDE for first-in-human artificial heart study

    massdevice.com

    https://www.massdevice.com/bivacor-fda-ide-artificial-heart-study/

    WebNovember 29, 2023 By Sean Whooley. The BiVacor Total Artificial Heart (TAH) [Image courtesy of BiVacor] BiVacor announced today that the FDA granted investigational device exemption (IDE) for...

    DA: 27 PA: 28 MOZ Rank: 20

  • BiVACOR wins IDE to start first-in-human study for artificial heart

    medicaldevice-network.com

    https://www.medicaldevice-network.com/news/bivacor-wins-ide-to-start-first-in-human-study-for-artificial-heart/

    WebNov 30, 2023 · News. BiVACOR wins IDE to start first-in-human study for artificial heart. The first-in-human study will evaluate the safety and feasibility of the total artificial heart to bridge the time to a heart transplant. Robert Barrie November 30, 2023. Share this article.

    DA: 18 PA: 39 MOZ Rank: 81

  • (127) Preclinical Evaluation of the Bivacor Total Artificial Heart

    jhltonline.org

    https://www.jhltonline.org/article/S1053-2498(23)00185-7/fulltext

    WebThe BiVACOR Total Artificial Heart (TAH) is designed as a short and long-term implantable replacement option for the failing human heart. The device combines rotary blood pump and magnetic levitation technology to produce a single, contact-free, spinning disc that reliably pumps blood to the systemic and pulmonary circulations.

    DA: 76 PA: 97 MOZ Rank: 57

  • The ongoing quest for the first total artificial heart as ... - Nature

    nature.com

    https://www.nature.com/articles/s41569-022-00723-8

    WebJun 6, 2022 · 13 Citations. 13 Altmetric. Metrics. Abstract. Many patients with end-stage heart disease die because of the scarcity of donor hearts. A total artificial heart (TAH), an implantable machine that...

    DA: 32 PA: 57 MOZ Rank: 46